Interim

CVCB Names Interim Chief Financial Officer; Outgoing 32-Year CFO Remains With Company as Strategic Growth Advisor

Retrieved on: 
Wednesday, October 5, 2022

She succeeds David A. Kinross, Executive Vice President, Chief Financial Officer, who will remain in a transitional finance role as the Companys Strategic Growth Advisor effective September 30, 2022.

Key Points: 
  • She succeeds David A. Kinross, Executive Vice President, Chief Financial Officer, who will remain in a transitional finance role as the Companys Strategic Growth Advisor effective September 30, 2022.
  • The professional recruitment firm of Chrisman & Company has been contracted to commence an executive search for a permanent Chief Financial Officer.
  • Crusinberry joined CVCB in 2000 and has served as Senior Vice President, Controller since 2011.
  • Having previously served for 10 years as CFO for an out-of-state community bank, she has over 40 years of financial accounting, auditing and compliance expertise.

Axalta schedules third-quarter 2022 earnings conference call

Retrieved on: 
Wednesday, October 5, 2022

GLEN MILLS, Pa., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Axalta Coating Systems (NYSE: AXTA), a leading global coatings company, will release its third-quarter 2022 financial results after the close of trading on Tuesday, October 25.

Key Points: 
  • GLEN MILLS, Pa., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Axalta Coating Systems (NYSE: AXTA), a leading global coatings company, will release its third-quarter 2022 financial results after the close of trading on Tuesday, October 25.
  • In addition, the company will host a conference call at 8 a.m.
  • Axalta is a global leader in the coatings industry, providing customers with innovative, colorful, beautiful and sustainable coatings solutions.
  • For more information visit axalta.com and follow us on LinkedIn and @axalta on Twitter.

Longeveron to Present at the Annual Dawson James Small Cap Growth Conference

Retrieved on: 
Wednesday, October 5, 2022

MIAMI, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that Chris Min, M.D., Ph.D., Interim Chief Executive Officer, and Chief Medical Officer at Longeveron, will present at the upcoming Dawson James Small Cap Growth Conference taking place in Jupiter, Florida from October 11-12, 2022.

Key Points: 
  • MIAMI, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that Chris Min, M.D., Ph.D., Interim Chief Executive Officer, and Chief Medical Officer at Longeveron, will present at the upcoming Dawson James Small Cap Growth Conference taking place in Jupiter, Florida from October 11-12, 2022.
  • A live webcast of the presentation can be accessed by visiting Events & Presentations in the Investors section of Longeverons website at https://www.longeveron.com/ .
  • Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs.
  • Longeveron is advancing Lomecel-B through clinical trials in three indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimers Disease, and Aging Frailty.

Fate Therapeutics to Present Clinical and Preclinical Data for iPSC Product Platform at the Society for Immunotherapy of Cancer 37th Annual Meeting

Retrieved on: 
Wednesday, October 5, 2022

Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.

Key Points: 
  • Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.
  • The Companys first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.
  • Fate Therapeutics iPSC product platform is supported by an intellectual property portfolio of over 350 issued patents and 150 pending patent applications.
  • Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer.

Second Annual RARE Health Equity Summit Addresses Gaps in Access, Shares Approaches to Build Inclusiveness in Underserved Communities

Retrieved on: 
Wednesday, October 5, 2022

Global Genes , a leading rare disease advocacy organization, will hold its second annual RARE Health Equity Summit in partnership with the Rare Disease Diversity Coalition (RDDC).

Key Points: 
  • Global Genes , a leading rare disease advocacy organization, will hold its second annual RARE Health Equity Summit in partnership with the Rare Disease Diversity Coalition (RDDC).
  • The event includes speakers from the FDA, community and patient organizations, academia and industry and will discuss approaches to address racial, ethnic, gender, socioeconomic and other disparities affecting rare disease communities.
  • The takeaways from last years inaugural Health Equity Summit highlighted the work that we must do as a community to break down barriers.
  • Black Womens Health Imperative (BWHI) launched the Rare Disease Diversity Coalition (RDDC) to address the extraordinary challenges faced by rare disease patients of color.

Halfords Group PLC: Acquisition of Lodge Tyre

Retrieved on: 
Wednesday, October 5, 2022

Halfords Group plc (Halfords or the Group), the UK's largest provider of Motoring and Cycling products and services, today announces the acquisition of LTC Trading Holdings Limited and its subsidiary Lodge Tyre Company (The) ("Lodge Tyre") (the "Acquisition") (the Company) for total consideration of 37.2 million (the Consideration) with 33.2 million paid on completion and 4 million paid in FY25 subject to performance.

Key Points: 
  • Halfords Group plc (Halfords or the Group), the UK's largest provider of Motoring and Cycling products and services, today announces the acquisition of LTC Trading Holdings Limited and its subsidiary Lodge Tyre Company (The) ("Lodge Tyre") (the "Acquisition") (the Company) for total consideration of 37.2 million (the Consideration) with 33.2 million paid on completion and 4 million paid in FY25 subject to performance.
  • Lodge Tyre is a well-established business in the UK commercial tyre market, providing automotive services to business-to-business ("B2B) customers from 50 garages and 248 mobile vans.
  • Graham Stapleton, Chief Executive Officer of Halfords, commented:
    "The acquisition of Lodge Tyre is yet another example of Halfords strategic aim of becoming a Motoring Services-focused business, and will mean that Motoring accounts for over three quarters of our total revenue.
  • Lodge Tyre is a highly respected business in the tyre and vehicle maintenance market, with a rich heritage dating back to 1935.

TreeHouse Foods Announces Webcast of Third Quarter 2022 Earnings Conference Call

Retrieved on: 
Tuesday, October 4, 2022

OAK BROOK, Ill., Oct. 4, 2022 /PRNewswire/ -- TreeHouse Foods, Inc. (NYSE: THS) will host an audio webcast of its third quarter earnings results conference call on Monday, November 7, 2022 at 8:30 a.m.

Key Points: 
  • OAK BROOK, Ill., Oct. 4, 2022 /PRNewswire/ -- TreeHouse Foods, Inc. (NYSE: THS) will host an audio webcast of its third quarter earnings results conference call on Monday, November 7, 2022 at 8:30 a.m.
  • A webcast replay will be available under the "Investors", "Events & Presentations", "Archived Events & Presentations" section of the Company's website.
  • TreeHouse Foods, Inc. is a leading manufacturer and distributor of private label foods and beverages in North America.
  • Additional information, including TreeHouse's most recent statements on Forms 10-Q and 10-K, may be found at TreeHouse's website, http://www.treehousefoods.com .

GAMUT LAUNCHES NEW SERVICE FOR LOCAL POLITICAL ADVERTISING

Retrieved on: 
Tuesday, October 4, 2022

NEW YORK, Oct. 4, 2022 /PRNewswire/ -- Gamut, a leader in local OTT advertising, announces the launch of a new service for targeted local political advertising. The proprietary service is specifically designed to be deployed beginning 40 days out from an election and gives marketers the ability to make their buys as efficiently as possible by targeting only voters online who have yet to vote in this election cycle.

Key Points: 
  • NEW YORK, Oct. 4, 2022 /PRNewswire/ -- Gamut , a leader in local OTT advertising, announces the launch of a new service for targeted local political advertising.
  • "This service greatly enhances our abilities to impact election outcome and solves critical challenges that all political marketers face," said Adam Gaynor, Gamut's Interim President and Chief Revenue Officer.
  • With guaranteed premium OTT inventory and a track record of delivering 99 percent of political bookings in full, Gamut provides the audiences, geo-locations, and impressions/GRPs political marketers need to offset these preemptions.
  • Gamut, the award-winning leader in local OTT media, helps brands connect with relevant streaming audiences in every DMA.

CCA Health California Announces New Health Plan Benefits for 2023

Retrieved on: 
Tuesday, October 4, 2022

CERRITOS, Calif., Oct. 4, 2022 /PRNewswire/ -- CCA Health California, a leading integrated healthcare organization with proven expertise in complex care coordination, today announced new Medicare Advantage health plan benefits for 2023. The CCA Medicare Excel (HMO) plan, previously known as the Choice plan, will be available to residents in Santa Clara and San Joaquin counties who are 65 and over and eligible for Medicare. Members can pay $0 for a broad spectrum of medical and behavioral health services and can receive extra benefits that help cover prescriptions, vision care, over-the-counter health products, transportation, telehealth, and worldwide emergency care. Residents can enroll in the plan during the Medicare Annual Enrollment Period, between October 15 and December 7, 2022.

Key Points: 
  • "CCA Health California is singularly focused on helping our Medicare members thrive and live well as they age" said Wil Yu , General Manager of CCA Health California.
  • "Our 2023 plan benefits were designed to meet the unique needs of the communities we serve and to address the social factors that can impact health outcomes the most.
  • Current CCA Health California members will not have to enroll to take advantage of these benefits as their membership will automatically renew in January 2023.
  • CCA Health California operates Medicare Advantage plans in San Joaquin and Santa Clara counties, offering benefits and services designed for high-need populations.

Appia Announces It Has Signed a Letter of Intent with the Fond Du Lac Denesuline First Nation

Retrieved on: 
Tuesday, October 4, 2022

The Letter of Intent reflects a meaningful relationship between Appia Rare Earths & Uranium Corp. and Fond du Lac who are working together for the mutual benefit of the Fond du Lac community as well as neighbouring communities within the Athabasca Region.

Key Points: 
  • The Letter of Intent reflects a meaningful relationship between Appia Rare Earths & Uranium Corp. and Fond du Lac who are working together for the mutual benefit of the Fond du Lac community as well as neighbouring communities within the Athabasca Region.
  • Appia and Fond du Lac have agreed to formulize their intentions following this Letter of Intent, and move this project forward by negotiating final agreements.
  • The continuing relationship with Fond du Lac can only generate substantial long-term economic and beneficial social opportunities for Fond du Lac and other stakeholders.
  • Chief Kevin Mercredi, Fond du Lac Denesuline First Nation, (Tel) 306-981-5047 or (email) [email protected]
    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/139451